nature.com search

Loading Filters

Showing 1–17 of 17 results

Loading Filters

Research | 19 March 2012
Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML
- M A Hospital
- , X Thomas
- , S Castaigne
- , E Raffoux
- , C Pautas
- , C Gardin
- , J-H Bourhis
- , O Reman
- , T de Revel
- , C Terré
- , C Preudhomme
- , P Fenaux
- , M Michallet
- , G Socié
- & H Dombret
Bone Marrow Transplantation 47 , 1436–1441

Rights & permissionsfor article Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML . Opens in a new window.
Comments and Opinion | 10 June 2004
Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia
- C Terre
- , V Eclache
- , P Rousselot
- , M Imbert
- , C Charrin
- , C Gervais
- , M J Mozziconacci
- , O Maarek
- , H Mossafa
- , N Auger
- , N Dastugue
- , P Talmant
- , J Van den Akker
- , C Leonard
- , F N'Guyen Khac
- , F Mugneret
- , F Viguié
- , M Lafage-Pochitaloff
- , J N Bastie
- , G L Roux
- , F Nicolini
- , F Maloisel
- , N Vey
- , G Laurent
- , C Recher
- , M Vigier
- , Y Yacouben
- , S Giraudier
- , J P Vernant
- , B Salles
- , J Roussi
- , S Castaigne
- , V Leymarie
- , G Flandrin
- & M Lessard
Leukemia 18 , 1340–1346

Rights & permissionsfor article Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia . Opens in a new window.
13 September 2007
Recurrent in-frame insertion in C/EBPα TAD2 region is a polymorphism without prognostic value in AML
- V Biggio
- , A Renneville
- , O Nibourel
- , N Philippe
- , L Terriou
- , C Roumier
- , P Amouyel
- , D Cottel
- , S Castaigne
- , H Dombret
- , X Thomas
- , P Fenaux
- & C Preudhomme
Leukemia 22 , 655–657

Rights & permissionsfor article Recurrent in-frame insertion in C/EBPα TAD2 region is a polymorphism without prognostic value in AML . Opens in a new window.
Research | 22 March 2004
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients
- C Cordonnier
- , S Maury
- , C Pautas
- , J N Bastié
- , S Chehata
- , S Castaigne
- , M Kuentz
- , S Bretagne
- & P Ribaud
Bone Marrow Transplantation 33 , 943–948

Rights & permissionsfor article Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients . Opens in a new window.
16 March 2006
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)
- C Kelaidi
- , L Ades
- , S Chevret
- , M Sanz
- , A Guerci
- , X Thomas
- , S de Botton
- , E Raffoux
- , C Rayon
- , N Fegueux
- , D Bordessoule
- , F Rigal-Huguet
- , H Link
- , A Stoppa
- , A Vekhoff
- , S Meyer-Monard
- , S Castaigne
- , H Dombret
- , L Degos
- & P Fenaux
Leukemia 20 , 905–907

Rights & permissionsfor article Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials) . Opens in a new window.
4 August 2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
- P Fenaux
- , S Chevret
- , A Guerci
- , N Fegueux
- , H Dombret
- , X Thomas
- , M Sanz
- , H Link
- , F Maloisel
- , C Gardin
- , D Bordessoule
- , A-M Stoppa
- , A Sadoun
- , P Muus
- , H Wandt
- , P Mineur
- , JA Whittaker
- , M Fey
- , M-T Daniel
- , S Castaigne
- & L Degos
Leukemia 14 , 1371–1377

Rights & permissionsfor article Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia . Opens in a new window.
15 July 2011
Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia
- A Renneville
- , N Boissel
- , N Helevaut
- , O Nibourel
- , C Terré
- , C Pautas
- , C Gardin
- , X Thomas
- , P Turlure
- , O Reman
- , C Berthon
- , H Dombret
- , S Castaigne
- & C Preudhomme
Leukemia 25 , 1918–1921

Rights & permissionsfor article Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia . Opens in a new window.
13 July 2006
Trisomy 4, a new chromosomal abnormality in Waldenström's macroglobulinemia: a study of 39 cases
- C Terré
- , F Nguyen-Khac
- , C Barin
- , M J Mozziconacci
- , V Eclache
- , C Léonard
- , E Chapiro
- , H Farhat
- , A Bouyon
- , P Rousselot
- , S Choquet
- , M Spentchian
- , P Dubreuil
- , V Leblond
- & S Castaigne
Leukemia 20 , 1634–1636

Rights & permissionsfor article Trisomy 4, a new chromosomal abnormality in Waldenström's macroglobulinemia: a study of 39 cases . Opens in a new window.
Research | 13 July 2006
Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study
- A Delannoy
- , E Delabesse
- , V Lhéritier
- , S Castaigne
- , F Rigal-Huguet
- , E Raffoux
- , F Garban
- , O Legrand
- , S Bologna
- , V Dubruille
- , P Turlure
- , O Reman
- , M Delain
- , F Isnard
- , D Coso
- , P Raby
- , A Buzyn
- , S Caillères
- , S Darre
- , C Fohrer
- , A Sonet
- , C Bilhou-Nabera
- , M-C Béné
- , H Dombret
- , P Berthaud
- & X Thomas
Leukemia 20 , 1526–1532

Rights & permissionsfor article Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study . Opens in a new window.
31 August 2000
Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study
- WK Hofmann
- , WJ Kell
- , P Fenaux
- , S Castaigne
- , A Ganser
- , C Chomienne
- , R Burnett
- , C Kowal
- , D Hoelzer
- & AK Burnett
Leukemia 14 , 1583–1588

Rights & permissionsfor article Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study . Opens in a new window.
3 January 2003
Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients
- F Maloisel
- , L Benboubker
- , M Gardembas
- , B Coiffier
- , M Divine
- , C Sebban
- , M Blanc
- , J-F Abgrall
- , P Lederlin
- , J-L Harousseau
- , A-M Blaise
- , B Grosbois
- , P Morice
- , C Ghandour
- & S Castaigne
Leukemia 17 , 45–51

Rights & permissionsfor article Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients . Opens in a new window.
7 October 1999
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients
- R Bouabdallah
- , F Lefrère
- , C Rose
- , P Chaïbi
- , J-L Harousseau
- , J-P Vernant
- , S Castaigne
- , F Bauduer
- , J-M Zini
- , D Coso
- , B Varet
- , J Robert
- & P Fenaux
Leukemia 13 , 1491–1496

Rights & permissionsfor article A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients . Opens in a new window.
Research | 19 October 2006
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group
- A-L Taksin
- , O Legrand
- , E Raffoux
- , T de Revel
- , X Thomas
- , N Contentin
- , R Bouabdallah
- , C Pautas
- , P Turlure
- , O Reman
- , C Gardin
- , B Varet
- , S de Botton
- , F Pousset
- , H Farhat
- , S Chevret
- , H Dombret
- & S Castaigne
Leukemia 21 , 66–71

Rights & permissionsfor article High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group . Opens in a new window.
30 August 2002
Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy
- N Boissel
- , JM Cayuela
- , C Preudhomme
- , X Thomas
- , N Grardel
- , X Fund
- , I Tigaud
- , E Raffoux
- , P Rousselot
- , F Sigaux
- , L Degos
- , S Castaigne
- , P Fenaux
- & H Dombret
Leukemia 16 , 1699–1704

Rights & permissionsfor article Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy . Opens in a new window.
Research | 25 January 2007
Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group
- X Thomas
- , E Raffoux
- , S de Botton
- , C Pautas
- , P Arnaud
- , T de Revel
- , O Reman
- , C Terré
- , B Corront
- , C Gardin
- , Q-H Le
- , B Quesnel
- , C Cordonnier
- , J-H Bourhis
- , M Elhamri
- , P Fenaux
- , C Preudhomme
- , M Michallet
- , S Castaigne
- & H Dombret
Leukemia 21 , 453–461

Rights & permissionsfor article Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group . Opens in a new window.
Research | 30 September 2016
Copy-number analysis identified new prognostic marker in acute myeloid leukemia
- O Nibourel
- , S Guihard
- , C Roumier
- , N Pottier
- , C Terre
- , A Paquet
- , P Peyrouze
- , S Geffroy
- , S Quentin
- , A Alberdi
- , R B Abdelali
- , A Renneville
- , C Demay
- , K Celli-Lebras
- , P Barbry
- , B Quesnel
- , S Castaigne
- , H Dombret
- , J Soulier
- , C Preudhomme
- & M H Cheok
Leukemia 31 , 555–564

Rights & permissionsfor article Copy-number analysis identified new prognostic marker in acute myeloid leukemia . Opens in a new window.
Research | 13 January 2012
Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
- A Renneville
- , N Boissel
- , O Nibourel
- , C Berthon
- , N Helevaut
- , C Gardin
- , J-M Cayuela
- , S Hayette
- , O Reman
- , N Contentin
- , D Bordessoule
- , C Pautas
- , S de Botton
- , T de Revel
- , C Terre
- , P Fenaux
- , X Thomas
- , S Castaigne
- , H Dombret
- & C Preudhomme
Leukemia 26 , 1247–1254

Rights & permissionsfor article Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association . Opens in a new window.

Refine your results by…

Filters

Filter By:

Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML

Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia

Recurrent in-frame insertion in C/EBPα TAD2 region is a polymorphism without prognostic value in AML

Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients

Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

Wilms' tumor 1 single-nucleotide polymorphism rs16754 does not predict clinical outcome in adult acute myeloid leukemia

Trisomy 4, a new chromosomal abnormality in Waldenström's macroglobulinemia: a study of 39 cases

Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study

Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group

Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy

Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

Copy-number analysis identified new prognostic marker in acute myeloid leukemia

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters